Results 161 to 170 of about 6,707 (187)
Some of the next articles are maybe not open access.

Protocol audit of dinoprostone gel induction of labour

Australian Midwifery, 2004
This study aimed to evaluate dinoprostone gel induction of labour. A prospective observational study was conducted over six months in 2001. Themes explored include predictive indicators within the Modified Bishop's Score, timing between doses, timing of administration and number of doses administered.
Charlene Thornton, Michael Whaites
openaire   +2 more sources

Is dinoprostone safe? A report of three maternal deaths

The Journal of Maternal-Fetal & Neonatal Medicine, 2009
We report three maternal deaths which might be in possible association with the use of intravaginal dinoprostone for cervical ripening and induction of labor. All cases occurred at our institution between January 2006 and December 2007. Uterine atony and profuse bleeding followed by disseminated intravascular coagulation (DIC), characterized by severe ...
Dede, Hulya   +4 more
openaire   +4 more sources

Cost-utility analysis for induction of labour with dinoprostone

European Journal of Hospital Pharmacy, 2012
Background Taylor and Armour assessed consumer preferences for two methods of induction of labour. This made it possible to conduct a cost-utility analysis; so far no study has been published including the quality of life parameter. Purpose To investigate whether dinoprostone vaginal gel or slow release pessaries have a better incremental cost ...
J.E. Poquet-Jornet   +4 more
openaire   +2 more sources

Induction of labour: A comparison between controlled‐release dinoprostone vaginal pessary (Cervidil®) and dinoprostone intravaginal gel (Prostin E2®)

Australian and New Zealand Journal of Obstetrics and Gynaecology, 2008
Background: There are various prostaglandin preparations available for inducing labour. Controlled‐release dinoprostone vaginal pessary is used in a number of centres in Australia and New Zealand.Aims: To compare the efficacy and safety of controlled‐release dinoprostone vaginal pessary (Cervidil®) with dinoprostone intravaginal gel (Prostin E2®) for ...
Lesley M. E. McCowan   +2 more
openaire   +3 more sources

Induction of labor at term using isosorbide mononitrate simultaneously with dinoprostone compared to dinoprostone treatment alone: A randomized, controlled trial

American Journal of Obstetrics and Gynecology, 2006
We aimed to determine whether isosorbide mononitrate (IMN) given simultaneously with dinoprostone in term pregnancies is superior to dinoprostone alone to promote delivery.One hundred and twenty nulliparous women at term were randomly assigned to receive per vaginam IMN 40 mg or placebo in addition to 3 mg dinoprostone 2 times daily for up to 2 days ...
Peter Husslein   +7 more
openaire   +3 more sources

Efficacy of Dinoprostone Gel [PDF]

open access: possibleDrug Intelligence & Clinical Pharmacy, 1988
Lori C. Neely, Linda L. Hart
openaire   +1 more source

Dinoprostone Vaginal Insert: A Review in Cervical Ripening

Drugs, 2018
Dinoprostone vaginal insert (Cervidil®; Propess®), a retrievable vaginal pessary containing 10 mg of dinoprostone [prostaglandin E2 (PGE2)] in a controlled-release drug delivery device, is approved in many countries worldwide for the initiation (or continuation) of cervical ripening in patients at term prior to labour induction.
openaire   +3 more sources

DINOPROSTONE VAGINAL INSERT FOR CERVICAL RIPENING AND LABOR INDUCTION

Obstetrics & Gynecology, 2001
To compare dinoprostone 10 mg controlled-release vaginal insert with other forms of vaginal or cervical prostaglandin for cervical ripening.Literature search strategy included review of the Cochrane database of randomized trials, on-line searching of MEDLINE, hand searching of bibliographies, and contact with authors of relevant reports.Randomized ...
Anthony J Kelly   +2 more
openaire   +3 more sources

[Controlled release vaginal dinoprostone for the induction of labour].

Minerva ginecologica, 2003
To study the efficacy and safety of controlled release dinoprostone (PGE2) for the induction of labour.From March 2001 to August 2002, a total of 173 patients hospitalized for postdate pregnancy, maternal hypertension, intrauterine delayed growth, reduction of amniotic fluid, were studied.
CIPRIANO L   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy